ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 130 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $54 | -18.2% | 16,346 | +0.3% | 0.00% | – |
| Q1 2024 | $66 | +32.0% | 16,292 | -0.3% | 0.00% | – |
| Q4 2023 | $50 | 0.0% | 16,345 | -1.0% | 0.00% | – |
| Q3 2023 | $50 | -18.0% | 16,511 | +1.3% | 0.00% | – |
| Q2 2023 | $61 | +10.9% | 16,304 | -0.4% | 0.00% | – |
| Q1 2023 | $55 | -75.3% | 16,377 | -64.6% | 0.00% | – |
| Q4 2022 | $223 | -99.9% | 46,277 | -0.0% | 0.00% | – |
| Q3 2022 | $263,000 | -19.6% | 46,290 | +0.5% | 0.00% | – |
| Q2 2022 | $327,000 | +14.7% | 46,049 | +16.7% | 0.00% | – |
| Q1 2022 | $285,000 | -31.5% | 39,450 | -15.1% | 0.00% | – |
| Q4 2021 | $416,000 | -74.6% | 46,487 | -0.4% | 0.00% | -100.0% |
| Q3 2021 | $1,636,000 | +37.4% | 46,675 | -15.8% | 0.00% | +100.0% |
| Q2 2021 | $1,191,000 | +39.8% | 55,461 | +301.9% | 0.00% | 0.0% |
| Q1 2021 | $852,000 | +80.5% | 13,800 | +22.1% | 0.00% | 0.0% |
| Q4 2020 | $472,000 | – | 11,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 5,462,079 | $16,659,341 | 12.62% |
| TANG CAPITAL MANAGEMENT LLC | 4,076,741 | $12,434,060 | 1.15% |
| Stonepine Capital Management, LLC | 839,514 | $2,560,518 | 1.11% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,581,196 | 0.73% |
| CM Management, LLC | 270,000 | $823,500 | 0.66% |
| EcoR1 Capital, LLC | 6,995,861 | $21,337,376 | 0.55% |
| Acuitas Investments, LLC | 171,098 | $615,373 | 0.32% |
| Newtyn Management, LLC | 508,474 | $1,550,846 | 0.30% |
| Diametric Capital, LP | 161,524 | $492,648 | 0.30% |
| Auour Investments LLC | 177,000 | $670,830 | 0.26% |